Antidepressant-like effect of PRE-084, a selective σ1 receptor agonist, in Albino Swiss and C57BL/6J mice

Pharmacological Reports

Volumn 61, Issue 6, 2009, Pages 1179-1183

  Skuza, Grazyna ^a   Rogóz, Zofia ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

BD 1047; Forced swim test; Mice; PRE 084; SM 21

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; ANTIDEPRESSANT AGENT; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; OPIATE ANTAGONIST; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; SM 21; TROPANYL 2 (4 CHLOROPHENOXY)BUTANOATE MALEATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; EXPERIMENTAL MODEL; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; RECEPTOR AFFINITY;

EID: 76049084560     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70181-1     Document Type: Article

References (25)

1. Bermack JE, Debonnel G: The role of sigma receptors in depression. J Pharmacol Sci, 2005, 97, 317-336.
2. David DJ, Renard CE, Jolliet P, Hascoët M, Bourin M: Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl), 2003, 166, 373-382.
3. Debonnel G, de Montigny C: Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. Life Sci, 1996, 58, 721-734.
4. Duman RS: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med, 2004, 5, 11-25.
5. 2 antagonist. Pharmacol Biochem Behav, 2000, 67, 659-662.
6. Guitart X, Codony X, Monroy X: Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl), 2004, 174, 301-319.
7. Martin WR, Eades CG, Thompson JA, Huppler E, Gilbert PE: The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther, 1976, 197, 517-532.
8. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR: Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol, 1995, 280, 301-310.
9. 2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice. Pharmacol Biochem Behav, 2007, 86, 86-91.
10. 1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol, 1996, 312, 267-271.
11. 1 ) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol. 1999, 81, 125-155.
12. 1 receptor-mediated behaviours are related to neurosteroid levels. Eur J Neurosci, 2002, 15, 1523-1534.
13. Porsolt RD, Bertin A, Jalfre M: Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther, 1977, 229, 327-236.
14. Rogóż Z, Skuza G, Legutko B: Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats. Pharmacol Rep, 2008, 60, 817-826.
15. Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP: Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res, 2009, 198, 472-476.
16. Sánchez C, Meier E: Behavioural profile of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology, 1997, 129, 197-205.
17. Skuza G: Potential antidepressant activity of sigma ligands. Pol J Pharmacol, 2003, 55, 923-934.
18. 1A receptor agonist in the forced swimming test in rats. Pharmacol Rep, 2007, 59, 773-777.
19. Su TP, Wu XZ, Cone EJ, Shukla K, Gund TM, Dodge AL, Parish DW: Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J Pharmacol Exp Ther, 1991, 259, 543-550.
20. Takebayashi M, Hayashi T, Su TP: Nerve growth factor-induced neurite sprouting in PC12 cells involves σ-1 receptors: implications for antidepressants. J Pharmacol Exp Ther, 2002, 303, 1227-1237.
21. Tran TT, de Costa BR, Matsumoto RR: Microinjection of sigma ligands into cranial nerve nuclei produces vacuous chewing in rats. Psychopharmacology (Berl), 1998, 137, 191-200.
22. 1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther, 2001, 298, 1269-1279.
23. Volz HP, Stoll KD: Clinical trials with sigma ligands. Pharmacopsychiatry, 2004, 37, Suppl 3, S214-220.
24. Wang J, Mack AL, Coop A, Matsumoto RR: Novel σ receptor agonists produce antidepressant-like effects in mice. Eur Neuropsychopharmacol, 2007, 17, 708-716.
25. Yagasaki Y, Numakawa T, Kumamaru E, Hayashi T, Su TP, Kunugi H: Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J Biol Chem, 2006, 281, 12941-12949.